Reimbursed medicines
by gross spend
Rank | Medicine | Therapeutic group | 2022 Spend |
---|---|---|---|
1 | Adalimumab | Immunosuppressants | $113.59 |
2 | Dabigatran | Antithrombotic Agents | $48.55 |
3 | Pembrolizumab | Immunosuppressants | $46.27 |
4 | Budesonide with eformoterol | Respiratory | $41.87 |
5 | Trastuzumab | Immunosuppressants | $40.08 |
6 | Lenalidomide | Oncology | $38.75 |
7 | Insulin glargine | Diabetes | $36.89 |
8 | Rivaroxaban | Antithrombotic Agents | $34.22 |
9 | Glecaprevir and pibrentasvir | Antivirals | $32.42 |
10 | Palbociclib | Oncology | $29.31 |
11 | Abiraterone acetate | Oncology | $28.71 |
12 | Rurioctocog alfa pegol [Recombinant factor VIII] | Blood and Blood Forming Organs | $27.22 |
13 | Etanercept | Immunosuppressants | $28.71 |
14 | Pneumococcal (PCV10) vaccine | Vaccinations | $24.14 |
15 | Aflibercept | Immunosuppressants | $24.07 |
16 | Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine | Vaccinations | $22.95 |
17 | Secukinumab | Immunosuppressants | $20.69 |
18 | Dolutegravir | Anti-infectives | $20.66 |
19 | Empaglifilozin | Diabetes | $20.04 |
20 | Human papillomavirus vaccine [HPV] | Vaccinations | $17.75 |
Total | $693.00 |